Regulation & Market Access

Technology serves as the foundational enabler for omnichannel marketing success, providing the infrastructure for data integration, personalization, automation, and real-time optimization. Without robust technological capabilities, true omnichannel engagement remains impossible to achieve at scale.1 Core Technology Infrastructure Requirements Customer Relationship Management (CRM) Systems form the central hub for omnichannel operations:2 Marketing Automation Platforms enable personalized engagement at scale:3 Data…

FAQ #5: What Are the Biggest Challenges in Implementing Omnichannel Marketing? Implementing omnichannel marketing in pharma and medtech faces significant organizational, technical, and cultural barriers that go beyond typical technology implementations. Understanding these challenges is crucial for developing effective change management strategies.1 Leadership and Cultural Barriers Mindset transformation represents the most understated yet critical challenge. Shifting to omnichannel…

FAQ #4: What Are the Main Benefits of Implementing Omnichannel Marketing? Implementing omnichannel marketing in pharma and medtech delivers measurable improvements across customer experience, operational efficiency, and business outcomes. Research demonstrates significant quantifiable benefits that justify the investment required for transformation.1 Enhanced Customer Experience and Engagement Personalized customer journeys represent the primary benefit, with 89% of first-time buyers…

FAQ #3: What Are the Key Components of a Successful Omnichannel Strategy? A successful omnichannel strategy in pharma and medtech requires four foundational pillars: strategy, content, technology, and execution capabilities. Each component must work in harmony to create the seamless customer experience that defines true omnichannel engagement.1 1. Strategic Foundation The foundation begins with deep customer understanding –…

What is MLR and why does it matter in pharma and MedTech marketing? MLR stands for Medical, Legal and Regulatory review. It is a mandatory, cross-functional process that ensures that all promotional, educational and informational materials are: In highly regulated industries like pharmaceuticals and MedTech, MLR approval is a critical checkpoint before any HCP-facing or…

What are the main forms of generative AI being leveraged in pharma marketing? Generative AI can be categorized into three general uses: What are the primary use cases for AI in pharma and MedTech marketing? There are four broad categories of AI use cases in pharma and MedTech marketing:

Common Pitfalls Fixes: Learn more at Scaling MedTech: From Product to Market This post is part of SaMD Europe Launch Guide. This content has been enhanced by GenAI tools.

Staying Compliant Post-Launch Post-market surveillance (PMS) is required for all devices. Requirements: For Class IIa+, submit PSUR every 1–2 years. This post is part of SaMD Europe Launch Guide. This content has been enhanced by GenAI tools.

CE Mark ≠ Reimbursement Each EU country has its own reimbursement process. Highlights: – Germany (DiGA): Fast track, 12-month provisional access – France: Multiple programs (ETAPES, PECAN) – UK: NICE approval + local commissioning (ICBs) Evidence needs differ, it can be Randomized Controlled Trials (RCTs) or real-world evidence depending on system. Learn more on Scaling…

MDR Requirements SaMD must show: Documentation: Use real-world evidence, literature, or clinical studies. This post is part of SaMD Europe Launch Guide. This content has been enhanced by GenAI tools.